Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

Overview of attention for article published in Digestive Diseases and Sciences, July 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 1 X user

patent: 34 patents

Citations

dimensions_citation: 257 Dimensions

Readers on

mendeley: 180 Mendeley

So far, Altmetric has seen 34 patents that reference this research output.

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

About this Attention Score

Mentioned by

Citations

Readers on

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11891368-B2

United States of America

Solid formulation and method for preventing or reducing coloration thereof

Grant US-11844822-B2

United States of America

Pharmaceutical formulation of odevixibat

Grant US-11802115-B2

United States of America

Pharmaceutical formulation of odevixibat

Grant US-11801226-B2

United States of America

Benzothiazepine compounds and their use as bile acid modulators

Grant US-11773071-B2

United States of America

IBAT inhibitors for the treatment of liver diseases

Grant US-11732006-B2

United States of America

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11708340-B2

United States of America

Benzothiadiazepine compounds and their use as bile acid modulators

Grant US-11603359-B2

United States of America

Treating progressive familial intrahepatic cholestasis (PFIC) with IBAT inhibitors

Grant US-11583539-B2

United States of America

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11572350-B1

United States of America

In vitro method for determining the adsorbing capacity of an insoluble adsorbant

Grant US-11549878-B2

United States of America

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11377429-B2

United States of America

Crystal modifications of odevixibat

Grant US-11365182-B2

United States of America

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11306064-B2

United States of America

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11267794-B2

United States of America

IBAT inhibitors for the treatment of liver diseases

Grant US-11261212-B2

United States of America

Benzothiadiazepine compounds and their use as bile acid modulators

Grant US-11225466-B2

United States of America

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11180465-B2

United States of America

Benzothia(di)azepine compounds and their use as bile acid modulators

Grant US-11111224-B2

United States of America

Benzothiazepine compounds and their use as bile acid modulators

Grant US-11014898-B1

United States of America

Oral cholestyramine formulation and use thereof

Grant US-11007142-B2

United States of America

IBAT inhibitors for the treatment of liver diseases

Grant US-10981952-B2

United States of America

Benzothiazepine compounds and their use as bile acid modulators

Grant US-10975045-B2

United States of America

Crystal modifications of odevixibat

Grant US-10975046-B2

United States of America

Benzothiadiazepine compounds and their use as bile acid modulators

Grant US-10941127-B2

United States of America